InflaRx NV Sustainability Reports
InflaRx N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class, potent, and specific inhibitors of C5a and its receptor C5aR to treat life-threatening inflammatory diseases.
Sector: Manufacturing
Country: Germany
Exchange: Nasdaq
LEI: 391200708PAUDLQ31581
FIGI: BBG00HZ6PLD2
5 reports from 2020 to 2025
